Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study
Abstract One of the major pathomechanisms of COVID-19 is the interplay of hyperinflammation and disruptions in coagulation processes, involving thrombocytes. Antiplatelet therapy (AP) by anti-inflammatory effect and inhibition of platelet aggregation may affect these pathways. The aim of this study...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Portfolio
2024-02-01
|
| 叢編: | Scientific Reports |
| 在線閱讀: | https://doi.org/10.1038/s41598-024-55407-9 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
